MDS Pharma Services Expands Development & Regulatory Services in Europe
01 August 2007 - 2:00PM
PR Newswire (US)
KING OF PRUSSIA, PA, Aug. 1 /PRNewswire-FirstCall/ -- MDS Pharma
Services, a leading provider of innovative drug discovery and
development solutions, announced today the expansion of its
Development & Regulatory Services (DRS) business in Europe. MDS
Pharma Services will now offer full-service DRS consulting services
to support development of new drugs and biopharmaceutical products
for clients in Europe. The MDS Pharma Services' European DRS
organization will also be fully integrated with consultants in the
United States and Canada to provide product development consulting,
program management, and regulatory affairs services for new drugs
and biopharmaceutical products. "This expansion in Europe will
greatly broaden our consulting capabilities in development and
regulatory services," said MDS Pharma Services President David
Spaight. "We will now be able to provide expertise to support our
biotechnology and Asian pharmaceutical clients in the process of
commercializing their products in North American and European
markets." This European expansion is being supported by the
appointments of two industry experts, Dr. Didier Saur, MD as
Vice-President of Medical Affairs, and Dr. Sarah Roberts, Ph.D. as
Senior Director of Regulatory Affairs. Based near Paris in Sevres,
France, Dr. Saur will lead the MDS Pharma Services product
development consulting, program management, and regulatory affairs
services for drugs and biopharmaceutical products in Europe. He
will also be responsible for organizing and chairing the Medical
Advisory Board for DRS. Dr. Saur has more than 20 years experience
as a physician in the pharmaceutical and contract research
industry. Trained in internal and intensive care medicine, clinical
pharmacology and statistics, he is a specialist in cardiovascular
and metabolic disorders such as diabetes and obesity. Based in
Winnersh, near London, Dr. Roberts will provide expert regulatory
affairs consulting for clients on European regulatory issues. An
oncology research specialist with more than 10 years experience,
Dr. Roberts has worked with the Dana Farber Cancer Institute in
Boston, Massachusetts and the Gray Cancer Institute in London,
England. She has considerable experience with regulatory agencies
in both North America and Europe, and most recently served as a
Director for Smart Regulatory Solutions Ltd, an independent
consulting firm she established. About MDS Pharma Services MDS
Pharma Services offers a full spectrum of resources to meet the
drug discovery and development needs of the pharmaceutical and
biotechnology industries. With numerous facilities strategically
located around the world, we apply advanced scientific and
technological expertise throughout the drug discovery and
development process - from lead optimization, pre-IND research,
early clinical research (bioequivalence, phases I-IIa) and
bioanalysis through to global clinical development (phases IIb-IV),
central lab and centralized cardiac services. For more information,
visit our website at http://www.mdsps.com/. MDS Pharma Services is
a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a global life
sciences company that provides market-leading products and services
our customers need for the development of drugs and diagnosis and
treatment of disease. We are a leading global provider of
pharmaceutical contract research, medical isotopes for molecular
imaging, radiotherapeutics, and analytical instruments. MDS has
more than 6,200 highly skilled people in 28 countries. Find out
more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. DATASOURCE: MDS Pharma Services CONTACT: For
Investors, Sharon Mathers, (416) 675-6777 ext. 34721, ; For Media,
Charlene McGrady, (610) 239-7900 ext. 231,
Copyright